Similar results have also been obtained by selective ablation of NG2 expression in tumor macrophages, resulting in impaired recruitment of CD18+ cells to the tumor region, and producing an extensive delay in tumor progression (165). This evidence concerns the gene ITGB2 and neoplasm.